PBX3 and central nervous system cancer: Another study revealed that PBX3 knockdown inhibited the MAPK signalling pathway by downregulating the expression of phosphorylated Raf‐1, p38 and ERK1/2, leading to proliferation inhibition and apoptosis promotion in glioma.79